Competing interests
The authors declare that they have no competing interests. Nicola Dalbeth has received consulting fees, speaker fees, or grants from AstraZeneca, Dyve Biosciences, Horizon, Amgen, Selecta, Arthrosi, JW Pharmaceutical Corporation, PK Med, PTC Therapeutics, Protalix, Cello Health, Abbvie, and Janssen, outside the submitted work.Other authors have nothing to disclose.